Swiss National Bank Buys 1,800 Shares of Twist Bioscience Co. (NASDAQ:TWST)

The Swiss National Bank (SNB) has recently announced that it has purchased 1,800 shares of Twist Bioscience Co. (NASDAQ: TWST). This investment represents a significant commitment to the company and its mission to develop innovative solutions for the life sciences industry.

Twist Bioscience is a leading provider of synthetic biology tools and reagents, with a focus on enabling researchers to design, synthesize, and analyze DNA sequences with unprecedented speed and accuracy. The company's products are used in a wide range of applications, including gene editing, drug discovery, and diagnostics.

The SNB's investment in Twist Bioscience is likely driven by the company's strong growth potential and its position at the forefront of the synthetic biology industry. In recent years, the market for synthetic biology tools has grown rapidly, as researchers and companies seek to harness the power of this technology to develop new products and solutions.

Twist Bioscience has been performing well financially, with strong revenue growth and a growing customer base. The company's stock price has also been performing well, with shares trading at around $100 as of August 2021.

Overall, the SNB's investment in Twist Bioscience is likely seen as a strategic move to position itself at the forefront of the synthetic biology industry and to capitalize on the company's strong growth potential.